Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Mediprocity
AddedFeb 18, 2024
UpdatedJun 18, 2026
Mediprocity

Mediprocity

Seed

Mediprocity: A secure messaging mobile app for the healthcare industry.

HQ
Chesterfield, MO, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

Mediprocity was founded with the mission to enhance communication within the healthcare industry through secure and compliant messaging solutions. The company's vision is to streamline and safeguard the exchange of sensitive information among healthcare providers. Mediprocity offers a suite of products including secure messaging, form delivery, prescription orders, and SureCount for inventory management, all designed to meet HIPAA compliance standards. Their market focus is on physicians, healthcare providers, and medical facilities, providing both mobile and desktop solutions.

Notable affiliates include healthcare professionals and IT security experts who contribute to the platform's development and compliance. Mediprocity has secured investments from key players in the health tech sector, bolstering its growth and innovation. The company has achieved significant milestones in ensuring HIPAA compliance and facilitating seamless communication in medical settings. Overall, Mediprocity has had a substantial impact on improving the efficiency and security of healthcare communications.

Mediprocity - Similar Companies

medEchat logo

medEchat

medechat.com

Medigram logo

Medigram

medigram.com

Medici logo

Medici

MedChat logo

MedChat

medchatapp.com

Conex Med/Pro Systems logo

Conex Med/Pro Systems

IM Your Doc logo

IM Your Doc

imyourdoc.com

MedThread logo

MedThread

medthread.com

MicroMed logo

MicroMed

RxVantage logo

RxVantage

rxvantage.com

Medifies logo

Medifies

medifies.com

Medcurity logo

Medcurity

medcurity.com

Medstro logo

Medstro

Medshift logo

Medshift

medshift.com

Medcorder logo

Medcorder

medcorder.com

Care Thread logo

Care Thread

Mediprocity - Quick Facts

Who are Mediprocity's competitors?

Companies similar to Mediprocity include medEchat, Medigram, Medici and MedChat.

When was Mediprocity founded?

Mediprocity was founded in 2009.

Where is Mediprocity's headquarters located?

Mediprocity's headquarters is located in Chesterfield, MO, US.

When was Mediprocity's last funding round?

Mediprocity's most recent funding round was for $182.5k (USD) in April 2016.

How much has Mediprocity raised to-date?

As of Apr 18, 2016, Mediprocity has raised a total of $232.5k (USD).

How many employees does Mediprocity have?

Mediprocity has 9 employees as of Feb 5, 2024.

Mediprocity - Classification

Ownership
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Small Business
Main Product
  • Forms
  • Messaging
Tags
  • Cloud
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 6 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7371Computer Programming Services